Cargando…
Risk factors for recurrent infection in the surgical treatment of infected massive endoprostheses implanted for musculoskeletal tumours
BACKGROUND: Infection is a devastating complication of endoprosthetic replacement (EPR) in orthopaedic oncology. Surgical treatments include debridement and/or one- or two-stage exchange. This study aims to determine the infection-free survival after surgical treatment for first and recurrent EPR in...
Autores principales: | Azamgarhi, Tariq, Warren, Simon, Aston, Will, Pollock, Rob, Gerrand, Craig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887870/ https://www.ncbi.nlm.nih.gov/pubmed/36717856 http://dx.doi.org/10.1186/s13018-022-03446-1 |
Ejemplares similares
-
Dalbavancin to Treat Infected Massive Endoprostheses: A Case Report and Cost Comparison Analysis
por: Azamgarhi, Tariq, et al.
Publicado: (2019) -
The Use of Massive Endoprostheses for the Treatment of Bone Metastases
por: Park, D. H., et al.
Publicado: (2007) -
Osteointegration of hydroxyapatite-coated collars in cemented massive endoprostheses following revision surgery
por: Davies, Benjamin, et al.
Publicado: (2021) -
A case of Trueperella pyogenes causing prosthetic joint infection
por: Azamgarhi, Tariq, et al.
Publicado: (2020) -
Cemented Distal Femoral Endoprostheses for Musculoskeletal Tumor: Improved Survival of Modular versus Custom Implants
por: Schwartz, Adam J., et al.
Publicado: (2009)